Casao, Christ-jhon A.
HRN: 20-54-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2023
MUPIROCIN 2%, 15G (TUBE)
09/13/2023
09/19/2023
TOPICAL
2%
BID
Post Iv Site
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes